LILRB1 and tuberculosis: Our findings reveal that leukocyte immunoglobulin like receptor B1 (LILRB1) and its ligand human leukocyte antigen-G (HLA-G) constitute a critical immune checkpoint axis to drive NK cell exhaustion in TB patients, thereby providing a promising target for TB immunotherapy.